全球靶向定序和定序市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計目標定序和定序市場將從 2025 年的 105.7 億美元成長到 2034 年的 686.4 億美元，2026 年至 2034 年的複合年成長率為 23.1%。

受基因組學和個人化醫療發展趨勢的推動，全球標靶定序和定序市場正經歷顯著成長。癌症診斷、罕見疾病和遺傳性疾病研究的日益增多，加速了標靶定序技術的應用。研究機構和臨床檢查室對經濟高效且精準的基因分析工具的需求也日益成長。

成長要素包括定序成本降低、生技研發投入增加以及次世代定序（NGS）應用範圍不斷擴大。製藥公司擴大利用標靶定序進行藥物發現和開發。精準醫療和伴隨診斷日益受到關注，進一步推動了全球市場需求。

展望未來，持續的技術創新和生物資訊學工具的整合有望提高數據準確性和處理速度。在新興市場，隨著醫療基礎設施的完善，預計應用範圍將進一步擴大。隨著基因組研究的不斷深入和人們對基因檢測認知的不斷提高，該市場具有強勁的長期成長潛力。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球標靶定序與定序市場：依技術分類

• 市場分析、洞察與預測
• 定序
• 重測序

第5章 全球標靶定序與定序市場：依應用分類

• 市場分析、洞察與預測
• 臨床應用
• 植物和動物科學
• 藥物研發
• 其他

第6章 全球標靶定序與定序市場：按類型分類

• 市場分析、洞察與預測
• 基於DNA的標靶定序
• 基於RNA的標靶定序

第7章 全球標靶定序與定序市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 學術研究
• 其他

第8章 全球標靶定序與定序市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Agilent Technologies
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc
  • Dnastar Inc
  • PacBio
  • Bio-Rad Laboratories Inc
  • Integrated DNA Technologies Inc
  • Perkin Elmer Inc
  • RainDance Technologies Inc
  • PierianDx

The Targeted Sequencing And Resequencing Market size is expected to reach USD 68.64 Billion in 2034 from USD 10.57 Billion (2025) growing at a CAGR of 23.1% during 2026-2034.

The Global Targeted Sequencing and Resequencing Market is experiencing significant growth driven by advancements in genomics and personalized medicine. Increasing research activities in cancer diagnostics, rare diseases, and genetic disorders have accelerated the adoption of targeted sequencing technologies. The demand for cost-effective and accurate gene analysis tools is expanding across research institutions and clinical laboratories.

Growth drivers include declining sequencing costs, rising investment in biotechnology research, and the growing application of next-generation sequencing (NGS). Pharmaceutical companies are increasingly using targeted resequencing for drug discovery and development. The expanding focus on precision medicine and companion diagnostics is further strengthening market demand worldwide.

Looking forward, continuous technological innovation and integration of bioinformatics tools are expected to enhance data accuracy and processing speed. Emerging markets are likely to witness increased adoption due to improving healthcare infrastructure. With ongoing advancements in genomics research and rising awareness about genetic testing, the market holds strong long-term growth potential.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Sequencing
• Re-Sequencing

By Application

• Clinical Application
• Plant And Animal Sciences
• Drug Development
• Others

By Type

• DNA-Based Targeted Sequencing
• RNA-Based Targeted Sequencing

By End-Use

• Hospitals & Clinics
• Academic Research
• Others

COMPANIES PROFILED

• Agilent Technologies, Illumina Inc, F HoffmannLa Roche Ltd, Thermo Fisher Scientific Inc, Dnastar Inc, PacBio, BioRad Laboratories Inc, Integrated DNA Technologies Inc, Perkin Elmer Inc, RainDance Technologies Inc, PierianDx
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Re-Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Clinical Application Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Plant And Animal Sciences Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Drug Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Type
• 6.2. DNA-Based Targeted Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. RNA-Based Targeted Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Technology
  • 8.2.2 By Application
  • 8.2.3 By Type
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Technology
  • 8.3.2 By Application
  • 8.3.3 By Type
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Technology
  • 8.4.2 By Application
  • 8.4.3 By Type
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Technology
  • 8.5.2 By Application
  • 8.5.3 By Type
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Technology
  • 8.6.2 By Application
  • 8.6.3 By Type
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL TARGETED SEQUENCING AND RESEQUENCING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Agilent Technologies
  • 10.2.2 Illumina Inc
  • 10.2.3 F. Hoffmann-La Roche Ltd
  • 10.2.4 Thermo Fisher Scientific Inc
  • 10.2.5 Dnastar Inc
  • 10.2.6 PacBio
  • 10.2.7 Bio-Rad Laboratories Inc
  • 10.2.8 Integrated DNA Technologies Inc
  • 10.2.9 Perkin Elmer Inc
  • 10.2.10 RainDance Technologies Inc
  • 10.2.11 PierianDx